SeaStar Medical Holding (ICU) Non Operating Interest Expenses (2022 - 2026)
SeaStar Medical Holding's (ICU) quarterly Non Operating Interest Expenses came in at $8000.0 in Q2 2026, down 97.32% on a YoY basis from $298000.0 in Q2 2025, and up 33.33% quarter-over-quarter from $6000.0 in Q1 2026.
Powered by 
Analysis
SeaStar Medical Holding (ICU) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has reported Non Operating Interest Expenses for 5 consecutive years, with $8000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 97.32% year-over-year to $8000.0; the trailing twelve-month figure through Jun 2026 stood at $14000.0 (down 95.73% YoY), and the FY2025 full-year result was $298000.0, up 22.13% from the prior year.
- Non Operating Interest Expenses improved to $8000.0 in Q2 2026 per ICU's latest filing, from $6000.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $433000.0 in Q1 2023 and bottomed at -$253000.0 in Q4 2024.
- Historically, Non Operating Interest Expenses has averaged $142375.0 across 5 years, with a median of $158000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses plunged 227.14% in 2024, then jumped 263.41% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $147000.0 in 2022, then surged by 35.37% to $199000.0 in 2023, then slumped by 227.14% to -$253000.0 in 2024, then jumped by 217.79% to $298000.0 in 2025, then slumped by 97.32% to $8000.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $8000.0, $6000.0, and $298000.0 for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 15.80 Mn |
| 10 | SeaStar Medical Holding | 12.74 Mn | 5.74 Mn | 561,000.00 | 8,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Jun 30, 2025 | 298,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -253,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 225,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 191,000.00 |
| Mar 31, 2022 | 169,000.00 |